Methods for Dose Selection or Modification in Rare Diseases or Small Populations

Methods for Dose Selection or Modification in Rare Diseases or Small Populations

Recorded On: 09/25/2024

Overview of the 2024 MIDD Webinar Series

The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.

Rena Byrne

Senior Scientist

Metrum Research Group

Rena Byrne is a Senior Scientist at Metrum Research Group, where she works on a variety of modeling and simulation projects to support MIDD in rare diseases, oncology, immunology, and diabetes. The types of analyses she works on include population PK and PD to support dose selection and filing, optimal sampling, and simulations in special populations. Her background is in biomedical engineering, and she got her start in the pharma industry as a lab scientist, supporting the discovery stage of drug development. She is certainly glad she learned about pharmacometrics early in her career and is happy to be doing meaningful and challenging work with wonderful colleagues and clients.

Key:

Complete
Failed
Available
Locked
MIDD Webinar Series | Methods for Dose Selection or Modification in Rare Diseases or Small Populations
Recorded 09/25/2024  |  60 minutes
Recorded 09/25/2024  |  60 minutes